Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis

Sharpless, Norman E, Ramsey, Matthew R, Balasubramanian, Periasamy, Castrillon, Diego H, DePinho, Ronald A · 2004 · Oncogene

Abstract

Mounting genetic evidence suggests that each product of the Ink4a/Arf locus, p16(INK4a) and p19(ARF), possesses tumor-suppressor activity (Kamijo et al., 1997; Krimpenfort et al., 2001; Sharpless et al., 2001a). We report the generation and characterization of a p19(ARF)-specific knockout allele (p19(ARF)-/-) and direct comparison with mice and derivative cells deficient for p16(INK4a), both p16(INK4a) and p19(ARF), and p53. Like Ink4a/Arf-/- murine embryo fibroblasts (MEFs), p19(ARF)-/- MEFs were highly susceptible to oncogenic transformation, exhibited enhanced subcloning efficiency at low density, and resisted both RAS- and culture-induced growth arrest. In contrast, the biological profile of p16(INK4a)-/- MEFs in these assays more closely resembled that of wild-type cells. In vivo, however, both p19(ARF)-/- and p16(INK4a)-/- animals were significantly more tumor prone than wild-type animals, but each less so than p53-/- or Ink4a/Arf-/- animals, and with differing tumor spectra. These data confirm the predominant role of p19(ARF) over p16(INK4a) in cell culture-based assays of MEFs, yet also underscore the importance of the analysis of tumor suppressors across many cell types within the organism. The cancer-prone conditions of mice singly deficient for either p16(INK4a) or p19(ARF) agree with data derived from human cancer genetics, and reinforce the view that both gene products play significant and nonredundant roles in suppressing malignant transformation in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1207074

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 2

  1. Festing M . (1998). Mouse Genome Informatics Web Site. Vol. 2001 The Jackson Laboratory: Bar Harbor, Maine.
  2. Sharpless NE, Kannan K, Xu J, Bosenberg M and Chin L . (2003). Oncogene. (in press).

Cited by

See all 225

Metadata

Authors
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Harvard University (US)
Corresponding author
Sharpless, Norman E
Venue
Oncogene
Published
2004-01-15
Volume
23
Issue
2
Pages
379-385
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2084912361
Cited by
224
References
36
Citations by year
2026: 4 · 2025: 5 · 2024: 4 · 2023: 10 · 2022: 11 · 2021: 6 · 2020: 5 · 2019: 10 · 2018: 5 · 2017: 8 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 14
FWCI
7.83
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • American Cancer Society
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
p16INK4a, p19ARF, INK4a/ARF locus, tumor suppressor, p53, knockout mice, mouse embryonic fibroblasts, oncogenic transformation, subclonal expansion, cancer susceptibility
MeSH terms
Alleles, Animals, Cell Division, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Fibroblasts, Genotype, Neoplasms, Phenotype, Tumor Suppressor Protein p53, Gene Deletion, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis. https://app.cochat.ai/papers/10.1038/sj.onc.1207074
The paper
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004). The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis. Oncogene. https://doi.org/10.1038/sj.onc.1207074

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.